カテゴリー： Market Monitor Global, 世界, 医療/バイオ

デクスランソプラゾールの世界市場見通し2023年-2029年

◆英語タイトル：Dexlansoprazole Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8462 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：79 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Dexlansoprazole Market 調査レポートは次の情報を含め、グローバルにおけるのデクスランソプラゾール市場規模と予測を収録しています。・世界のデクスランソプラゾール市場：売上、2018年-2023年、2024年-2029年
・世界のデクスランソプラゾール市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のデクスランソプラゾール市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「30mg」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

デクスランソプラゾールのグローバル主要企業は、Takeda、 Cardinal Health、 Suzhou Homesun Pharmaceutical、 Frontida、 Zhendong Group、 Ouya Pharmaceutical、 Heron Pharmaceutical、 Sailongなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、デクスランソプラゾールのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のデクスランソプラゾール市場：タイプ別、2018年-2023年、2024年-2029年
世界のデクスランソプラゾール市場：タイプ別市場シェア、2022年
・30mg、60mg

世界のデクスランソプラゾール市場：用途別、2018年-2023年、2024年-2029年
世界のデクスランソプラゾール市場：用途別市場シェア、2022年
・胃食道逆流症、びらん性食道炎治療

世界のデクスランソプラゾール市場：地域・国別、2018年-2023年、2024年-2029年
世界のデクスランソプラゾール市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるデクスランソプラゾールのグローバル売上、2018年-2023年
・主要企業におけるデクスランソプラゾールのグローバル売上シェア、2022年
・主要企業におけるデクスランソプラゾールのグローバル販売量、2018年-2023年
・主要企業におけるデクスランソプラゾールのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Takeda、 Cardinal Health、 Suzhou Homesun Pharmaceutical、 Frontida、 Zhendong Group、 Ouya Pharmaceutical、 Heron Pharmaceutical、 Sailong

*************************************************************

・調査・分析レポートの概要
デクスランソプラゾール市場の定義
市場セグメント
世界のデクスランソプラゾール市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のデクスランソプラゾール市場規模
世界のデクスランソプラゾール市場規模：2022年 VS 2029年
世界のデクスランソプラゾール市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのデクスランソプラゾールの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のデクスランソプラゾール製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：30mg、60mg
デクスランソプラゾールのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：胃食道逆流症、びらん性食道炎治療
デクスランソプラゾールの用途別グローバル売上・予測

・地域別市場分析
地域別デクスランソプラゾール市場規模 2022年と2029年
地域別デクスランソプラゾール売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Takeda、 Cardinal Health、 Suzhou Homesun Pharmaceutical、 Frontida、 Zhendong Group、 Ouya Pharmaceutical、 Heron Pharmaceutical、 Sailong
...

Dexlansoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach. Dexlansoprazole is used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to heal erosive esophagitis (damage to the esophagus from stomach acid).
This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole. This report contains market size and forecasts of Dexlansoprazole in global, including the following market information:
Global Dexlansoprazole Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dexlansoprazole Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dexlansoprazole companies in 2022 (%)
The global Dexlansoprazole market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
30 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dexlansoprazole include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dexlansoprazole manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dexlansoprazole Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dexlansoprazole Market Segment Percentages, by Type, 2022 (%)
30 mg
60 mg
Global Dexlansoprazole Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dexlansoprazole Market Segment Percentages, by Application, 2022 (%)
Gastroesophageal Reflux Disease
Heal Erosive Esophagitis
Global Dexlansoprazole Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dexlansoprazole Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dexlansoprazole revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dexlansoprazole revenues share in global market, 2022 (%)
Key companies Dexlansoprazole sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dexlansoprazole sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Cardinal Health
Suzhou Homesun Pharmaceutical
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dexlansoprazole, market overview.
Chapter 2: Global Dexlansoprazole market size in revenue and volume.
Chapter 3: Detailed analysis of Dexlansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dexlansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dexlansoprazole capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Dexlansoprazole Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dexlansoprazole Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dexlansoprazole Overall Market Size
2.1 Global Dexlansoprazole Market Size: 2022 VS 2029
2.2 Global Dexlansoprazole Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dexlansoprazole Sales: 2018-2029
3 Company Landscape
3.1 Top Dexlansoprazole Players in Global Market
3.2 Top Global Dexlansoprazole Companies Ranked by Revenue
3.3 Global Dexlansoprazole Revenue by Companies
3.4 Global Dexlansoprazole Sales by Companies
3.5 Global Dexlansoprazole Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dexlansoprazole Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dexlansoprazole Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dexlansoprazole Players in Global Market
3.8.1 List of Global Tier 1 Dexlansoprazole Companies
3.8.2 List of Global Tier 2 and Tier 3 Dexlansoprazole Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dexlansoprazole Market Size Markets, 2022 & 2029
4.1.2 30 mg
4.1.3 60 mg
4.2 By Type – Global Dexlansoprazole Revenue & Forecasts
4.2.1 By Type – Global Dexlansoprazole Revenue, 2018-2023
4.2.2 By Type – Global Dexlansoprazole Revenue, 2024-2029
4.2.3 By Type – Global Dexlansoprazole Revenue Market Share, 2018-2029
4.3 By Type – Global Dexlansoprazole Sales & Forecasts
4.3.1 By Type – Global Dexlansoprazole Sales, 2018-2023
4.3.2 By Type – Global Dexlansoprazole Sales, 2024-2029
4.3.3 By Type – Global Dexlansoprazole Sales Market Share, 2018-2029
4.4 By Type – Global Dexlansoprazole Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dexlansoprazole Market Size, 2022 & 2029
5.1.2 Gastroesophageal Reflux Disease
5.1.3 Heal Erosive Esophagitis
5.2 By Application – Global Dexlansoprazole Revenue & Forecasts
5.2.1 By Application – Global Dexlansoprazole Revenue, 2018-2023
5.2.2 By Application – Global Dexlansoprazole Revenue, 2024-2029
5.2.3 By Application – Global Dexlansoprazole Revenue Market Share, 2018-2029
5.3 By Application – Global Dexlansoprazole Sales & Forecasts
5.3.1 By Application – Global Dexlansoprazole Sales, 2018-2023
5.3.2 By Application – Global Dexlansoprazole Sales, 2024-2029
5.3.3 By Application – Global Dexlansoprazole Sales Market Share, 2018-2029
5.4 By Application – Global Dexlansoprazole Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dexlansoprazole Market Size, 2022 & 2029
6.2 By Region – Global Dexlansoprazole Revenue & Forecasts
6.2.1 By Region – Global Dexlansoprazole Revenue, 2018-2023
6.2.2 By Region – Global Dexlansoprazole Revenue, 2024-2029
6.2.3 By Region – Global Dexlansoprazole Revenue Market Share, 2018-2029
6.3 By Region – Global Dexlansoprazole Sales & Forecasts
6.3.1 By Region – Global Dexlansoprazole Sales, 2018-2023
6.3.2 By Region – Global Dexlansoprazole Sales, 2024-2029
6.3.3 By Region – Global Dexlansoprazole Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dexlansoprazole Revenue, 2018-2029
6.4.2 By Country – North America Dexlansoprazole Sales, 2018-2029
6.4.3 US Dexlansoprazole Market Size, 2018-2029
6.4.4 Canada Dexlansoprazole Market Size, 2018-2029
6.4.5 Mexico Dexlansoprazole Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dexlansoprazole Revenue, 2018-2029
6.5.2 By Country – Europe Dexlansoprazole Sales, 2018-2029
6.5.3 Germany Dexlansoprazole Market Size, 2018-2029
6.5.4 France Dexlansoprazole Market Size, 2018-2029
6.5.5 U.K. Dexlansoprazole Market Size, 2018-2029
6.5.6 Italy Dexlansoprazole Market Size, 2018-2029
6.5.7 Russia Dexlansoprazole Market Size, 2018-2029
6.5.8 Nordic Countries Dexlansoprazole Market Size, 2018-2029
6.5.9 Benelux Dexlansoprazole Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dexlansoprazole Revenue, 2018-2029
6.6.2 By Region – Asia Dexlansoprazole Sales, 2018-2029
6.6.3 China Dexlansoprazole Market Size, 2018-2029
6.6.4 Japan Dexlansoprazole Market Size, 2018-2029
6.6.5 South Korea Dexlansoprazole Market Size, 2018-2029
6.6.6 Southeast Asia Dexlansoprazole Market Size, 2018-2029
6.6.7 India Dexlansoprazole Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dexlansoprazole Revenue, 2018-2029
6.7.2 By Country – South America Dexlansoprazole Sales, 2018-2029
6.7.3 Brazil Dexlansoprazole Market Size, 2018-2029
6.7.4 Argentina Dexlansoprazole Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dexlansoprazole Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dexlansoprazole Sales, 2018-2029
6.8.3 Turkey Dexlansoprazole Market Size, 2018-2029
6.8.4 Israel Dexlansoprazole Market Size, 2018-2029
6.8.5 Saudi Arabia Dexlansoprazole Market Size, 2018-2029
6.8.6 UAE Dexlansoprazole Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Dexlansoprazole Major Product Offerings
7.1.4 Takeda Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 Cardinal Health
7.2.1 Cardinal Health Company Summary
7.2.2 Cardinal Health Business Overview
7.2.3 Cardinal Health Dexlansoprazole Major Product Offerings
7.2.4 Cardinal Health Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.2.5 Cardinal Health Key News & Latest Developments
7.3 Suzhou Homesun Pharmaceutical
7.3.1 Suzhou Homesun Pharmaceutical Company Summary
7.3.2 Suzhou Homesun Pharmaceutical Business Overview
7.3.3 Suzhou Homesun Pharmaceutical Dexlansoprazole Major Product Offerings
7.3.4 Suzhou Homesun Pharmaceutical Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.3.5 Suzhou Homesun Pharmaceutical Key News & Latest Developments
7.4 Frontida
7.4.1 Frontida Company Summary
7.4.2 Frontida Business Overview
7.4.3 Frontida Dexlansoprazole Major Product Offerings
7.4.4 Frontida Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.4.5 Frontida Key News & Latest Developments
7.5 Zhendong Group
7.5.1 Zhendong Group Company Summary
7.5.2 Zhendong Group Business Overview
7.5.3 Zhendong Group Dexlansoprazole Major Product Offerings
7.5.4 Zhendong Group Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.5.5 Zhendong Group Key News & Latest Developments
7.6 Ouya Pharmaceutical
7.6.1 Ouya Pharmaceutical Company Summary
7.6.2 Ouya Pharmaceutical Business Overview
7.6.3 Ouya Pharmaceutical Dexlansoprazole Major Product Offerings
7.6.4 Ouya Pharmaceutical Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.6.5 Ouya Pharmaceutical Key News & Latest Developments
7.7 Heron Pharmaceutical
7.7.1 Heron Pharmaceutical Company Summary
7.7.2 Heron Pharmaceutical Business Overview
7.7.3 Heron Pharmaceutical Dexlansoprazole Major Product Offerings
7.7.4 Heron Pharmaceutical Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.7.5 Heron Pharmaceutical Key News & Latest Developments
7.8 Sailong
7.8.1 Sailong Company Summary
7.8.2 Sailong Business Overview
7.8.3 Sailong Dexlansoprazole Major Product Offerings
7.8.4 Sailong Dexlansoprazole Sales and Revenue in Global (2018-2023)
7.8.5 Sailong Key News & Latest Developments
8 Global Dexlansoprazole Production Capacity, Analysis
8.1 Global Dexlansoprazole Production Capacity, 2018-2029
8.2 Dexlansoprazole Production Capacity of Key Manufacturers in Global Market
8.3 Global Dexlansoprazole Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dexlansoprazole Supply Chain Analysis
10.1 Dexlansoprazole Industry Value Chain
10.2 Dexlansoprazole Upstream Market
10.3 Dexlansoprazole Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dexlansoprazole Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dexlansoprazole in Global Market
Table 2. Top Dexlansoprazole Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dexlansoprazole Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dexlansoprazole Revenue Share by Companies, 2018-2023
Table 5. Global Dexlansoprazole Sales by Companies, (K Units), 2018-2023
Table 6. Global Dexlansoprazole Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dexlansoprazole Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Dexlansoprazole Product Type
Table 9. List of Global Tier 1 Dexlansoprazole Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dexlansoprazole Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Dexlansoprazole Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dexlansoprazole Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dexlansoprazole Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dexlansoprazole Sales (K Units), 2018-2023
Table 15. By Type - Global Dexlansoprazole Sales (K Units), 2024-2029
Table 16. By Application – Global Dexlansoprazole Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dexlansoprazole Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dexlansoprazole Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dexlansoprazole Sales (K Units), 2018-2023
Table 20. By Application - Global Dexlansoprazole Sales (K Units), 2024-2029
Table 21. By Region – Global Dexlansoprazole Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dexlansoprazole Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dexlansoprazole Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dexlansoprazole Sales (K Units), 2018-2023
Table 25. By Region - Global Dexlansoprazole Sales (K Units), 2024-2029
Table 26. By Country - North America Dexlansoprazole Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dexlansoprazole Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dexlansoprazole Sales, (K Units), 2018-2023
Table 29. By Country - North America Dexlansoprazole Sales, (K Units), 2024-2029
Table 30. By Country - Europe Dexlansoprazole Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dexlansoprazole Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dexlansoprazole Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dexlansoprazole Sales, (K Units), 2024-2029
Table 34. By Region - Asia Dexlansoprazole Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dexlansoprazole Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dexlansoprazole Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dexlansoprazole Sales, (K Units), 2024-2029
Table 38. By Country - South America Dexlansoprazole Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dexlansoprazole Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dexlansoprazole Sales, (K Units), 2018-2023
Table 41. By Country - South America Dexlansoprazole Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Dexlansoprazole Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dexlansoprazole Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dexlansoprazole Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dexlansoprazole Sales, (K Units), 2024-2029
Table 46. Takeda Company Summary
Table 47. Takeda Dexlansoprazole Product Offerings
Table 48. Takeda Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Takeda Key News & Latest Developments
Table 50. Cardinal Health Company Summary
Table 51. Cardinal Health Dexlansoprazole Product Offerings
Table 52. Cardinal Health Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Cardinal Health Key News & Latest Developments
Table 54. Suzhou Homesun Pharmaceutical Company Summary
Table 55. Suzhou Homesun Pharmaceutical Dexlansoprazole Product Offerings
Table 56. Suzhou Homesun Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Suzhou Homesun Pharmaceutical Key News & Latest Developments
Table 58. Frontida Company Summary
Table 59. Frontida Dexlansoprazole Product Offerings
Table 60. Frontida Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Frontida Key News & Latest Developments
Table 62. Zhendong Group Company Summary
Table 63. Zhendong Group Dexlansoprazole Product Offerings
Table 64. Zhendong Group Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Zhendong Group Key News & Latest Developments
Table 66. Ouya Pharmaceutical Company Summary
Table 67. Ouya Pharmaceutical Dexlansoprazole Product Offerings
Table 68. Ouya Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Ouya Pharmaceutical Key News & Latest Developments
Table 70. Heron Pharmaceutical Company Summary
Table 71. Heron Pharmaceutical Dexlansoprazole Product Offerings
Table 72. Heron Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Heron Pharmaceutical Key News & Latest Developments
Table 74. Sailong Company Summary
Table 75. Sailong Dexlansoprazole Product Offerings
Table 76. Sailong Dexlansoprazole Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sailong Key News & Latest Developments
Table 78. Dexlansoprazole Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Dexlansoprazole Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Dexlansoprazole Production by Region, 2018-2023 (K Units)
Table 81. Global Dexlansoprazole Production by Region, 2024-2029 (K Units)
Table 82. Dexlansoprazole Market Opportunities & Trends in Global Market
Table 83. Dexlansoprazole Market Drivers in Global Market
Table 84. Dexlansoprazole Market Restraints in Global Market
Table 85. Dexlansoprazole Raw Materials
Table 86. Dexlansoprazole Raw Materials Suppliers in Global Market
Table 87. Typical Dexlansoprazole Downstream
Table 88. Dexlansoprazole Downstream Clients in Global Market
Table 89. Dexlansoprazole Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dexlansoprazole Segment by Type in 2022
Figure 2. Dexlansoprazole Segment by Application in 2022
Figure 3. Global Dexlansoprazole Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dexlansoprazole Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dexlansoprazole Revenue, 2018-2029 (US$, Mn)
Figure 7. Dexlansoprazole Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dexlansoprazole Revenue in 2022
Figure 9. By Type - Global Dexlansoprazole Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dexlansoprazole Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dexlansoprazole Sales Market Share, 2018-2029
Figure 12. By Type - Global Dexlansoprazole Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Dexlansoprazole Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dexlansoprazole Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dexlansoprazole Sales Market Share, 2018-2029
Figure 16. By Application - Global Dexlansoprazole Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Dexlansoprazole Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dexlansoprazole Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dexlansoprazole Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dexlansoprazole Sales Market Share, 2018-2029
Figure 21. By Country - North America Dexlansoprazole Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dexlansoprazole Sales Market Share, 2018-2029
Figure 23. US Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dexlansoprazole Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dexlansoprazole Sales Market Share, 2018-2029
Figure 28. Germany Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 29. France Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dexlansoprazole Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dexlansoprazole Sales Market Share, 2018-2029
Figure 37. China Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 41. India Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dexlansoprazole Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dexlansoprazole Sales Market Share, 2018-2029
Figure 44. Brazil Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dexlansoprazole Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dexlansoprazole Sales Market Share, 2018-2029
Figure 48. Turkey Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dexlansoprazole Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dexlansoprazole Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Dexlansoprazole by Region, 2022 VS 2029
Figure 54. Dexlansoprazole Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ デクスランソプラゾールの世界市場見通し2023年-2029年(Dexlansoprazole Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

デクスランソプラゾールの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp